Tidetron, a Chinese startup that uses synthetic biology to produce raw materials for industries from skincare to biopharmaceuticals, has closed an IDG Capital-led new funding round that brought its total fundraising size to over $100 million, the investor announced on Monday.

”The startup started with serving clients in the consumer sector – such as cosmetics, food & beverage, and domestic appliances – with raw materials that require a shorter R&D cycle and have a lower threshold to achieve mass production.Zhang said that Tidetron generated nearly 100 million yuan ($15.7 million) in revenue for the whole year of 2021. The startup is looking to expand the size of its team to 170-200 people by the end of 2022. Tidetron was founded in 2021 by Zhang Zhiqian, a doctoral student in clinical medicine at the Zhongshan School of Medicine at Sun Yat-sun University in southern China’s Guangzhou City.

China’s Tidetron Crosses $100M In Funding After Idg-Led New Round

Description

Company Information

Funding Insights

China’s Tidetron Crosses $100M In Funding After Idg-Led New Round

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information